Objective To investigate whether ω-3 fatty acids reduce magnetic resonance imaging (MRI)
and clinical disease activity in patients with multiple sclerosis, both as monotherapy and in …

Objective: To investigate whether serum neurofilament light chain (NF-L) and chitinase 3-like
1 (CHI3L1) predict disease activity in relapsing-remitting MS (RRMS). Methods: A cohort of …

Objective: Studies based on deseasonalized vitamin D levels suggest that vitamin D may
influence the disease activity in multiple sclerosis (MS), and high doses are suggested as add-…

Vitamin D is emerging as a probably important environmental risk factor in multiple sclerosis,
affecting both susceptibility and disease progression. It is not known to what extent this …

Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is
largely unknown. Understanding the development of protective immunity is of paramount …

Background: Previous reports indicate an association between Epstein-Barr virus (EBV)
antibody levels and multiple sclerosis (MS) disease activity, but the results have been conflicting…

Obesity is a possible risk factor of multiple sclerosis (MS), but the association between
obesity and MS disease activity has not been explored. In a cohort of 86 MS patients, 80% of …

In multiple sclerosis (MS), the correlation between lesion load on conventional magnetic
resonance imaging (MRI) and clinical disability is weak. This clinico-radiological paradox might …

Vitamin D supplementation is increasingly recommended to patients with multiple sclerosis
( MS ). To study the effect of high‐dose vitamin D on remyelination, female C57Bl/6 mice …

Background: Vitamin A has immunomodulatory properties and may regulate the transcription
of genes involved in remyelination. Objective: To investigate the association between …